Health
Clinical trial to test existing antibiotic for treating serious S. aureus infections begins – News-Medical.Net
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun.
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun. The trial will enroll 200 adults hospitalized with complicated S. aureus infection at approximately 20 trial sites around the United States. The trial is being sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
S. aureus is a leading cause of antibiotic-resistant infection….
-
Noosa News23 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News24 hours agoE-biker charged with riding dangerously, assaulting cop
-
General22 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Business17 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today